ZymoGenetics: Clinical Trials

2 trials sponsored by ZymoGenetics, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 42Completed 2

Follow ZymoGenetics: new trials by email

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety and Immunogenicity Study of Recombinant Thrombin (rThrombin) in Pediatric Participants
rThrombin, 1000 IU/mL - Blood Loss, Surgical
Phase 4CompletedZymoGenetics302009-03-012012-01-26
Immunogenicity and Safety Study of rThrombin in Surgical Hemostasis
rThrombin, 1000 IU/mL - Blood Loss, Surgical
Phase 4CompletedZymoGenetics312009-01-012011-12-08

Conditions studied

Blood Loss, Surgical (2)

Interventions

Thrombin (2)  ·  recombinant human thrombin (2)

Countries

United States (2)

Top investigators

Kevin Foster, MD (1)  ·  Neil Singla, MD (1)

Results publications

PMID 22008340, PMID 38837237